Sunmary Around 60% of oral squamous cell carcinomas (SCCs) have been shown to harbour p53 mutations. and other studies have demonstrated mutant p53 genes in normal and dysplastic squamous epithelium adjacent to these SCCs. In line with these earlier studies we show here that DOK, a keratinocyte cell line derived from a dysplasia. displays elevated levels of p53 protein and harbours a 12 bp in-frame deletion of the p53 gene spanning codons [188][189][190][191]. In contrast, the coding region of the p53 gene was normal in a series of six benign recurrent laryngeal papillomas and a series of four premalignant oral erythroplakia biopsies and their cell cultures. All but one of these lesions were free of malignancy at the time of biopsy, in contrast to the premalignant lesions studied by previous investigators, but keratinocytes cultured from these lesions all displayed a partially transformed phenotype that was less pronounced than that of DOK. Since Squamous cell carcinoma of the head and neck (SCC-HN) is an extremely common tumour worldwide (Pindborg, 1984; Million et al.. 1989 ). yet little is known of the molecular mechanisms which result in its development. Some SCC-HN arise from premalignant lesions such as papillomas, leukoplakias and erythroplakias. while others do not. Papillomas in humans are essentially benign, with only a small percentage (less than 1%) progressing to malignancy, but leukoplakias and more usually erythroplakias do progress to malignancy (Pindborg, 1985) .
Squamous cell carcinoma of the head and neck (SCC-HN) is an extremely common tumour worldwide (Pindborg, 1984; Million et al.. 1989 ). yet little is known of the molecular mechanisms which result in its development. Some SCC-HN arise from premalignant lesions such as papillomas, leukoplakias and erythroplakias. while others do not. Papillomas in humans are essentially benign, with only a small percentage (less than 1%) progressing to malignancy, but leukoplakias and more usually erythroplakias do progress to malignancy (Pindborg, 1985) .
The p53 tumour-suppressor gene has been implicated in the pathogenesis of SCC-HN and is commonly mutated or deleted in tumours from Caucasian populations (Brachman et al., 1992; Jung et al., 1992; Maestro et al., 1992; Somers et al.. 1992; Boyle et al., 1993; Burns et al., 1993; Chung et al., 1993; Nees et al.. 1993) . In many cases this leads to stabilisation of the p53 protein, rendering it unusually detectable by immunocytochemistry (Field et al., 1991; Gusterson et al., 1991; Maestro et al., 1992; Burns et al., 1993) . Elevated levels of p53 protein have also been reported in histologically normal oral mucosa and dysplastic tissue adjacent to SCCs of the oral cavity (Gusterson et al.. 1991; Ogden et al., 1992) and larynx (Dolcetti et al., 1992) and also in the more basal cells of recurrent (Clark et al., 1993a) but not solitary (Ogden et al.. 1992) laryngeal papillomas. This has led some authors to speculate that mutation of p53 might be an early event in the development of SCC-HN (Dolcetti et al.. 1992) . and very recently it has been shown that at least in some instances both histologically normal (Nees et al., 1993) and dysplastic (Boyle et al.. 1993 ) oral epithelia harbour mutant p53 genes.
Most of these mutants. however, are likely to be of the stable (Oren et al.. 1981) and possibly gain-of-function type (Halevy et al.. 1990 ) since they result in increased levels of p53 protein (Dolcetti et al.. 1992; Nees et al.. 1993) . It is less certain whether loss of p53 suppressor function can influence squamous neoplasia at such an early stage. since in mouse multistage SCC development p53 loss appears to influence only the later stages of progression to carcinoma (Kemp et al.. 1993) .
The p53 protein has also been shown to be targeted for degradation by the E6 protein of the more oncogenic human papillomaviruses (HPV; Scheffner et al., 1990; Werness et al.. 1990) and by some investigators to be complexed, but not degraded, by the E6 proteins of the less oncogenic HPV types 6 or 11 (Crook et al.. 1991) . HPV types 2 (de Villiers et al.. 1985; Adler-Storthz et al., 1986 ), 4 (Yeudall & Campo, 1991 . 16 (Maitland et al.. 1987 (Maitland et al.. . 1989 Yeudall & Campo. 1991; Brachman et al., 1992) . 18 (Yeudall & Campo, 1991) and 33 (Snijders et al., 1992) have been reported from malignant SCC-HN. types 6 and 11 from recurrent laryngeal papillomas (Gissman et al., 1982; Mounts et al., 1982) and types 16 and 18 from papillomas, leukoplakias, dysplasias, keratoses and lichen planus (Loning et al., 1985; Maitland et al.. 1987) .
In order to understand further the molecular events which give rise to premalignant head and neck lesions and influence their progression, we have examined the p53 and HPV status of several of these neoplasms and the phenotypically characterised cultures derived from them. (Clark et al., 1993a) , the four erythroplakia cultures (Edington et al., 1994) and the cell line DOK (Chang et al., 1992) have all been described previously.
Cultivation and properties of the premalignant keratinocv tes The human papilloma (BICR P2. BICR P5) and erythroplakia (BICR El. BICR E2. BICR E4. BICR ES) keratinocvtes were cultured on lethally irradiated Swiss 3T3 feeder cells in Dulbecco's modified Eagle medium. 20% (v v) fetal bovine serum. 0.4 g ml-' hydrocortisone and 10 ng mlcholera toxin as descnrbed previously (Edington et al.. 1994) . DOK cells were cultured in the same wax except that 10o (v v) fetal bovine serum was used and cholera toxin was omitted. The properties of the cells are listed in Table II (Edington et al.. 1994) al.. 1989) . In some cases PCR products were deposited on nylon filters and probed for HPV sequences as described by Yeudall and Campo (1991) . The samples were also screened for the L1 consensus region of HPV types 1. 5. 6. 11. 16. 18. 26. 27. 31. 33, 35. 39. 40. 41, 42, 45, 47. 48 
Results
The status of the p53 tumour-suppressor gene in premalignant tissues and cells The p53 coding region was sequenced across exons 5-9 for all six papilloma biopsies and for the cell line DOK since all p53 mutations reported in SCC-HN have so far occurred within this region (Brachman et al.. 1992; Jung et al.. 1992; Maestro et al.. 1992; Sakai & Tsuchida, 1992; Somers et al.. 1992; Boyle et al., 1993; Burns et al., 1993; Chung et al.. 1993; Nees et al.. 1993) . The four erythroplakia cultures were sequenced across their entire coding region (Table III) . No p53 mutations were found in any of the samples or cultures with the exception of the cell line DOK (Table III) . which harboured a 12 bp in-frame deletion of codons 188-191 inclusive (Figure 1 ). We performed direct sequencing of the reverse-transcribed RNA of DOK. but no expression of the normal p53 allele was detectable, suggesting that the normal allele had been lost or that its expression had been suppressed by some other mechanism. The 12 bp deletion in the DOK cell line appeared to result in the stabilisation of the p53 protein since it was readily detectable by both PAb 1801 (Figure 2a ) and PAb 240 (Figure 2b ) antibodies followed by immunoperoxidase staining. Antibody PAb 1620, which does not recognise fixed or mutant p53, gave only weak background staining (Figure 2c) (Clark et al.. 1993b ).
Detection of human papillomavirus tipes in premalignant squamous tissues and cell Since several HPV types are known to infect the upper aerodigestive tract and the E6 proteins of some of these types have been proposed to inactivate p53 (Scheffner et al., 1990; Werness et al.. 1990; Crook et al.. 1991) . we screened for the presence of HPV in our samples. Figure 3 shows the detection of the E6 DNA of either HPV types 6 or 11 in each of six adult recurrent human laryngeal papillomas. All the papillomas contained either the E6 DNA of HPV type 6 or 11 but never both (Table III) . None of the erythroplakia tissues. their cell cultures or the cell line DOK contained detectable HPV type 6 or 11 E6 DNA (Table III) .
It is still unclear how mutation of the p53 tumour-suppressor gene influences the development and progression of SCC-HN. There is evidence that mutations of the p53 gene which lead to stabilisation of the protein give keratinocytes a selective advantage at an early stage of SCC development (Gusterson et al., 1991; Dolcetti et al.. 1992; Ogden et al.. 1992; Nees et al.. 1993) . and it is possible that these mutants are of the gain-of-function transforming class (Halevy et al.. 1990 ). However, experiments using p53 null mice and their heterozygotes suggest that mere loss of p53 function influences only progression from the premalignant to the malignant state during progression to SCC (Kemp et mutations at all. even at a late stage of tumour progression. and these same tumours lack detectable HPV (Brachman et al., 1992) . Therefore. there may be SCCs which arise by a mechanism in which p53 dysfunction cannot bestow a selective advantage on the developing tumour cells until a very late stage. if at all. Therefore. premalignant human oral keratinocyte cultures which lack both p53 mutation and oncogenic HPV types would be useful to test the role of p53 dysfunction in progression towards SCC. In this paper we have tested several human premalignant cultures to identify such cultures.
Six laryngeal papillomas and two of their cell cultures were shown to have normal p53 genes spanning codons 126-331 (Table III) . but all of them harboured either HPV 6 or HPV 11 E6 sequences (Figure 3 . Table III) . Since it has been reported that the E6 protein of HPV types 6 or 11 binds p53 in vitro (Crook et al.. 1991) . it is possible that the presence of these viruses partially inactivates the p53 protein in these cells and may explain the unusually high levels of p53 protein found in the more basal layers of recurrent papillomas in vivo which we reported previously (Clark et al.. 1993a) . Therefore, cultures of laryngeal papilloma cells would not be ideal materal to investigate the role of p53 in progression to SCC as they could not be guaranteed to possess a normal-functioning p53 protein.
We also investigated the p53 status of five premalignant keratinocyte cultures which were isolated from either squamous dysplasias or carcinomas in situ (Table I) . None contained detectable oncogenic HPV E6 or L 1 DNA sequences (Table III) so there was no evidence to support the inactivation of p53 by these viruses. The cell line DOK (Chang et al.. 1992) did. however, possess a homozygous 12 bp deletion of the p53 coding region (Figure 1 and Table  III) and expressed elevated levels of the p53 protein ( Figure  2a and b). Since DOK was isolated from dysplastic epithelium adjacent to an SCC of the tongue (Chang et al., 1992) and the presence of p53 mutations has been reported from such lesions (Boyle et al.. 1993) . it is not surprising that this cell line harbours a p53 mutation. Nevertheless, since DOK is non-tumorigenic (Chang et al.. 1992) it should be useful in the study or identification of mutations which cooperate with mutant p53 to effect progression towards SCC.
In contrast, all of the keratinocyte strains derived from premalignant oral erythroplakias lacked a p53 mutation in the coding sequence, and at least two (BICR E4 and BICR E5) have not lost heterozygosity at the p53 locus (Edington et al., 1994) . making a mutation outside the coding sequence also unlikely. We have considered several possibilities to explain our results. First. the erythroplakia keratinocytes might be in fact be normal cells since they have diploid karyotypes and senesce in culture (Table II) . However, all four BICR keratinocyte strains from erythroplakias showed a reduced rate of terminal maturation when placed in suspension culture (Edington et (Wille et al., 1984) , which supports extensive proliferation of normal keratinocytes (Edington et al., 1994 (Stanton et al.. 1994 ). This is not surprising in view of the evidence that one of the functions of p53 is to maintain genetic stability (Bischoff et al.. 1990; Kastan et al., 1991; Lane, 1992; Livingstone et al., 1992; Yin et al., 1992) and the data showing that DOK cells possess a homozygous deletion within the p53 gene.
It is, however, still uncertain whether the erythroplakia keratinocytes are at an earlier stage of tumour progression than DOK or whether they represent the precursor lesion of a type of SCC-HN which arises by a p53-independent mechanism. The availability of a series of premalignant erythroplakia keratinocytes which possess normal p53 genes now permits us to address these questions by manipulating the p53 status of these cells. 
